Wolfe Research analyst Andy Chen initiated coverage of Roivant Sciences with an Outperform rating.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ROIV:
- Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update
- Roivant Sciences reports Q3 EPS $6.03, consensus (32c)
- ROIV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Jefferies ‘encouraged thus far’ by Arbutus patent hearing
- JPMorgan biotech analysts to hold an analyst/industry conference call